Kidney dysfunction is often accompanied by complications that extend beyond the renal system, and the lungs are among the most affected organs. Fluid overload resulting from impaired filtration can lead to pulmonary edema, causing shortness of breath and reduced oxygen exchange. Uremic toxins can also weaken respiratory muscle performance, reduce ventilatory drive, and contribute to systemic inflammation that worsens lung function. Patients with chronic kidney disease are at a higher risk of respiratory infections, pleural effusions, and obstructive sleep apnea, which further complicate disease management. Identifying these manifestations early is critical to reduce morbidity and mortality in this vulnerable population.
Addressing kidney disease–related respiratory problems requires an integrated approach that targets both renal and pulmonary health. Dialysis plays a central role in controlling fluid balance and limiting pulmonary congestion, while optimized use of diuretics, oxygen therapy, and ventilatory support help stabilize respiratory status. Preventive measures, including timely vaccination, infection control strategies, and nutritional guidance, are essential for long-term well-being. Collaborative care between nephrologists, pulmonologists, and critical care specialists ensures accurate diagnosis and tailored therapy. Research into the kidney–lung axis is also expanding, providing insights into shared inflammatory pathways and molecular targets that may shape future therapies for these interconnected conditions.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation